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Introduction
Macrophage Activation Syndrome (MAS) is a severe
complication of rheumatic diseases, frequently asso-
ciated with systemic juvenile idiopathic arthritis (sJIA),
but also described in others pediatric inflammatory dis-
orders including Juvenile Systemic Lupus Erythematosus
(SLE) and Kawasaki disease. Due to the close resem-
blance to a group of histiocytic disorders collectively
known as hemophagocytic lymphohistiocytosis (HLH) it
is currently classified among the secondary or acquired
forms of HLH, and the term rheu-HLH has been
proposed.
Objectives
To describe clinical, functional and genetic features of
MAS in the Italian HLH registry.
Methods
We reviewed the HLH Italian National Registry to select
patients with MAS defined according to the diagnostic
criteria established by the Histiocyte Society (so called
HLH criteria) with confirmed diagnosis of rheumatolo-
gic or autoimmune disease. Clinical data were collected.
Functional screening of perforin expression and degra-
nulation was performed using flow-citometry. Genetic
study was carried out by direct sequencing of currently
known genes that cause familial HLH.
Results
Among the 813 patients referred to the Registry, 38 (5%)
were diagnosed as MAS in the context of a rheumatic dis-
ease. Of them 13 were male and 25 female; 30 Caucasian
and 8 Indian. Median age was 94 (quartiles: 37; 94; 136;
708) months. The underlying diseases were: sJIA (n = 28),
SLE (n = 4), Kawasaki disease (n = 1), Juvenile Dermato-
myositis (n = 1), undefined rheumatologic (n = 3) or auto-
immune (n = 1) disease. The clinical features included:
fever (n = 28/28, 100%), splenomegaly (n = 17/28, 61%),
neurologic manifestations (n = 7/28, 25%), anemia (n =
15/25, 60%), thrombocytopenia (n = 14/25, 56%), neutro-
penia (n = 3/25, 12%), hypertriglyceridemia (n = 14/25,
56%), hypofibrinogenemia (n = 7/25, 28%), hyperferritine-
mia (n = 22/23, 96%; quartiles: 2.430, 10.264, 15.953,
96.000 ng/ml), hemophagocytosis (n = 9/25, 36%). Four
patients (10.5%) died for disease progression. Functional
screening of FHL was performed in 22 cases: perforin
expression was normal in 14 and reduced in 8 (36%);
degranulation was defective in 3/18 (17%) and normal in
the remaining 15/18 cases. At least one test was defective
in 10/23 (43%). Mutation analysis included PRF1 (n = 36),
UNC13d (n = 22), STX11 (n = 33) and STXBP2 (n = 19)
and allowed to identify monoallelic mutations in 11 of the
38 patients (29%), as follows: PRF1 (n = 8/36, 22%),
STX11 (1/33, 3%), STXBP2 (3/19, 16%).
Conclusion
A significant portion of patients with MAS appear to
have functionally defective cytotoxic activity and carry
monoallelic variants in genes associated with familial
HLH. These data suggest additional similarities in
genetic background and cytotoxic activity abnormalities
between MAS associated with rheumatic diseases and
familial HLH.
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